Myoinositol - new possibility in treatment of polycystic ovary syndrome

Abstract

Myoinositol is an insulin sensitizing agent. It is used in the management of polycystic ovary syndrome.

It ameliorates the metabolit profile. It improves quality and quantity of oocytes in women with PSOS.

Hirsutism and acneare reduced by myoinositol.

Keywords

• anovulation hyperandrogenic cutaneous disorders
• hyperinsulinemia
• Inofolic®
• myoinositol
• polycystic ovary syndrome